Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 1007-1014

  Wright, Clifford D ^a   Havill, Andrew M ^a   Middleton, Scot C ^a   Kashem, Mohammed A ^a   Lee, Patrice A ^a   Dripps, David J ^a   O'Riordan, Thomas G ^b   Bevilacqua, Michael P ^a   Abraham, William M ^b  

^a AMGEN INC   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CARBACHOL; HISTAMINE; OVALBUMIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERINE PROTEINASE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASCARIS SUUM; ASTHMA; BRONCHOSPASM; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GUINEA PIG; INHALATIONAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LEUKOCYTE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEEP; TRACHEA MUCUS;

AEROSOLS; ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; FEMALE; GUINEA PIGS; HUMANS; INFLAMMATION; LUNG; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MUCUS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; RESPIRATORY MECHANICS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEINASE INHIBITORS; SHEEP; TRACHEA;

EID: 0032949984     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Abbinante-Nissen JM, Simpson LG and Leikauf GD (1995) Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol (Lung Cell Mol Physiol) 12:L601-L606.
2. Abraham WM, Ahmed A, Cortes A, Sielczak MW, Hinz W, Bouska J, Lanni C and Bell RL (1992) The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation, and airway hyperresponsiveness in allergic sheep. Eur J Pharmacol 217:119-126.
3. Abraham WM, Lanes S, Stevenson JS and Yerger LD (1986) Effect of an inhaled glucocorticosteroid (budesonide) on post-antigen induced increases in airway responsiveness. Bull Eur Physiopathol Respir 22:387-392.
4. Andersson P (1981) Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs. The effect of booster injection and cyclophosphamide treatment. Int Arch Allergy Appl Immunol 64:249-258.
5. Blyth DI, Pedrick MS, Savage TJ, Hessel EM and Fattah D (1996) Lung inflammation and epithelial changes in a marine model of atopic asthma. Am J Respir Cell Mol Biol 13:425-438.
6. Chand N, Nolan K, Pillar J, Lomask M, Diamantis W and Sofia RD (1993) Aeroallergen-induced dyspnea in freely moving guinea pigs: quantitative measurement by bias flow ventilated whole body plethysmography. Allergy 48:230-235.
7. Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, Warne RL, Moore WR and Tanaka RD (1995) Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 152:2076-2083.
8. Delaria K and Muller D (1996) High-performance liquid chromatographic assay for tryptase based on the hydrolysis of dansyl-vasoactive intestinal peptide. Anal Biochem 236:74-81.
9. DelMar EG, Largman C, Brodrick JW and Geokas MC (1979) A sensitive new substrate for chymotrypsin. Anal Biochem 99:316-320.
10. Dietze SC, Sommerhoff CP and Fritz H (1990) Inhibition of histamine release from human mast cells ex vivo by natural and synthetic chymase inhibitors. Biol Chem Hoppe-Seyler 371 (Suppl):75-79.
11. Dunnill MS (1960) The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27-33.
12. Eden E, Mitchell D, Mehlman B, Khouli H, Nejat M, Grieco MH and Turino GM (1997) Atopy, asthma, and emphysema in patients with severe α-1-antitrypsin deficiency. Am J Respir Crit Care Med 156:68-74.
13. Eisenberg SP, Hale KK, Heimdal P and Thompson RC (1990) Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 265:7976-7981.
14. Fahy JV, Kim KW, Liu J and Boushey HA (1995) Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 95:843-852.
15. Faller B, Mely Y, Gerard D and Bieth JG (1992) Heparin-induced conformational change and activation of mucus proteinase inhibitor. Biochemistry 31:8285-8290.
16. Fath MA, Wu X, Hileman RE, Linhardt RJ, Kashem MA, Nelson RM, Wright CD and Abraham WM (1998) Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J Biol Chem 273:13563-13569.
17. Forteza R, Botvinnikova Y, Ahmed A, Cortes A, Gundel RH, Wanner A and Abraham WM (1996) The interaction of α1-proteinase inhibitor and tissue kallikrein in controlling allergic ovine airway hyperresponsiveness. Am J Respir Crit Care Med 154:36-42.
18. Fujimoto K, Kubo K, Shinozaki S, Okada K, Matsuzawa Y, Kobayashi T and Sugane K (1995) Neutrophil elastase inhibitor reduces asthmatic responses in allergic sheep. Respir Physiol 100:91-100.
19. Groutas WC, Brubaker MJ, Venkataraman R, Epp JB, Stanga MA and McClenahan JJ (1992) Inhibitors of human neutrophil cathepsin G: Structural and biochemical studies. Arch Biochem. Biophys 294:144-146.
20. He S and Walls AF (1997) Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 328:89-97.
21. Imamura T, Dubin A, Moore W, Tanaka R and Travis J (1996) Induction of vascular permeability enhancement by human tryptase: Dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 74:861-870.
22. Kramps JA, van Twisk C and van der Linden AC (1983) L-Pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elaetase. Scand J Clin Lab Invest 43:427-432.
23. Lottenberg R, Christensen U, Jackson CM and Coleman PL (1981) Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol 80:341-361.
24. Lucey EC, Stone PJ, Ciccolella DE, Breuer R, Christensen TG, Thompson RC and Snider GL (1990) Recombinant human secretory leukocyte-protease inhibitor: In vitro properties and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster. J Lab Clin Med 115:224-232.
25. McElvaney NF, Doujaiji B, Moan MJ, Burnham MR, Wu MC and Crystal RG (1993) Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis 148:1056-1060.
26. Mendis AH, Venaille TJ and Robinson BW (1990) Study of human epithelial cell detachment and damage: Effects of proteases and oxidants. Immunol Cell Biol 68:95-105.
27. Molinari JF, Scuri M, Moore WR, Clark J, Tanaka R and Abraham WM (1996) Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am J Respir Crit Care Med 154:649-653.
28. O'Riordan TG, Mao YM, Otero R, Lopez J, Sabater JR and Abraham WM (1998) Budesonide affects allergic mucociliary dysfunction. J Appl Physiol 85:1086-1091.
29. O'Riordan TG, Otero R, Mao Y, Lauredo I and Abraham WM (1997) Elastase contributes to antigen-induced mucociliary dysfunction in ovine airways. Am Rev Respir Crit Care Med 155:1522-1528.
30. Ruoss SJ, Hartmann T and Caughey GH (1991) Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88:493-499.
31. Somorin O, Tokura S, Nishi N and Noguchi J (1979) The action of trypsin on synthetic chromogenic arginine substrates. J Biochem 85:157-162.
32. Stockley RA, Morrison HM, Kramps JA, Dijkman JH and Burnett D (1986) Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment. Thorax 41:442-447.
33. Stolk J, Camps J, Feitsma HIJ, Hermans J, Dijkman JH and Pauwels EKJ (1995) Pulmonary disposition and disappearance of aerosolised secretory leucocyte protease inhibitor. Thorax 50:645-650.
34. Suzuki T, Wang W, Lin J-T, Shirato K, Mitsuhashi H and Inoue H (1996) Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor. Am J Respir Crit Care Med 153:1405-1411.
35. Thompson RC and Ohlsson K (1986) Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Nail Acad Sci USA 83:6692-6696.
36. Venaille TJ, Mendis AHW, Phillips MJ, Thompson PJ and Robinson BWS (1995) Role of neutrophils in mediating human epithelial cell detachment from native basement membrane. J Allergy Clin Immunol 95:597-606.
37. Vogelmeier C, Buhl R, Hoyt RF, Wilson E, Fell GA, Hubbard RC, Schnebli H-P, Thompson RC and Crystal RG (1990) Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium. J Appl Physiol 69:1843-1848.
38. Walls AF, He S, Teran LM, Buckley MG, Jung K-S, Holgate ST, Shute JK and Cairns JA (1995) Granulocyte recruitment by human mast cell tryptase. Int Arch Allergy Immunol 107:372-373.
39. Wenzel SE, Fowler AA III and Schwartz LB (1988) Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vitro release of histamine and tryptase in atopic subject with and without asthma. Am Rev Respir Dis 137:1002-1008.
40. Zitnik RJ, Zhang J, Kashem MA, Kohno T, Lyons DE, Wright CD, Rosen E, Goldberg I and Hayday AC (1997) The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochem Biophys Res Commun 232:687-697.